Zygomycoses in patients with acute leukaemia

Annals of Hematology

Volumn 85, Issue 5, 2006, Pages 327-332

  Schalk, Enrico ^a   Mohren, Martin ^a   Jentsch Ullrich, Kathleen ^a   Dombrowski, Frank ^a   Franke, Astrid ^a   Koenigsmann, Michael ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Acute leukaemia; Breakthrough infection; Neutropenic fever; Voriconazole; Zygomycosis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; CASPOFUNGIN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; BRAIN HEMORRHAGE; CASE REPORT; DEATH; DEBRIDEMENT; DRUG DOSE REGIMEN; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN TISSUE; LUNG ASPERGILLOSIS; MALE; MUCORMYCOSIS; NASAL BIOPSY; PARANASAL SINUSITIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SEPSIS; SYMPTOM; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA; MALE; MIDDLE AGED; NEUTROPENIA; PYRIMIDINES; TRIAZOLES; ZYGOMYCOSIS;

EID: 33646677936     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-006-0082-8     Document Type: Review

References (39)

1. Andresen D, Donaldson A, Chao L, Knox A, Klaassen M, Ursic C, Vonthethoff L, Krilis S, Konecny P (2005) Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka. Lancet 365:876-878
2. Balasubramanian L, Trifilio SM, Tallman M, Mehta J, Bennett C (2005) Breakthrough zygomycoses in patients receiving antifungal therapy with voriconazole. J Clin Oncol 23(16S):601S (Abstract 6664)
3. Böhme A, Ruhnke M, Buchheidt D, Karthaus M, Einsele H, Guth S, Heussel G, Heussel CP, Junghanss C, Kern WK, Kubin T, Maschmeyer G, Sezer O, Silling G, Südhof T, Szelenyi H, Ullmann, AJ (2003) Treatment of fungal infections in hematology and oncology. Guidelines of the infectious diseases working party (AGIHO) of the German society of hematology and oncology (DGHO). Ann Hematol 82(suppl 2):S133-S140
4. Chandrasekar P (2005) Riches usher dilemmas: Antifungal therapy in invasive Aspergillosis. Biol Blood Marrow Transplant 11:77-84
5. Doucette KE, Galbraith PA, Bow EJ, Binda BJ, Rendina A, Embil JM (2003) Disseminated zygomycosis: A rare cause of infection in patients with hematologic malignancies. J Trauma 55:568-570
6. Gangat N, Khan MA, Mujib M, Khurshid M (2004) Pulmonary infiltrates during chemotherapy-induced febrile neutropenia: Incidence, patterns and outcomes. J Pak Med Assoc 54:285-288
7. Ghannoum MA, Kuhn DM (2002) Voriconazole - better chances for patients with invasive mycoses. Eur J Med Res 7:242-256
8. Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn RM, Walsh TJ (2005) Inteferon-γ and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis 191:1180-1187
9. Glazer M, Nusair S, Breuer R, Lafair J, Sherman Y, Berkman N (2000) The role of BAL in the diagnosis of pulmonary mucormycosis. Chest 117:279-282
10. Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E (2004) Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma 45:1351-1360
11. Greenberg RN, Anstead G, Herbrecht R, Langston A, Marr K, Mullane K, Raad I, Schiller G, Schuster M, Van Burik J, Wingard JR, Hare R, Corcoran G (2003) Posaconazole (POS) experience in the treatment of zygomycosis. In: 43rd Interscience conference on antimicrobial agent and chemotherapy abstracts; Chicago, Illinois; 2003 Sept 14-17; Abstract M-1757. American Society for Microbiology, Washington, District of Columbia
12. Greenberg RN, Scott LJ, Vaughn HH, Ribes JA (2004) Zygomycosis (mucormycosis): Emerging clinical importance and new treatments. Curr Opin Infect Dis 17:517-525
13. Herbrecht R (2004) Posaconazole: A potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections. Int J Clin Pract 58:612-624
14. Imhof A, Balajee A, Fredricks DN, Englund JA, Marr KA (2004) Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 39:743-746
15. Jagarlamudi R, Kumar L, Kochupillai V, Kapil A, Banerjee U, Thulkar S (2000) Infections in acute leukemia: An analysis of 240 febrile episodes. Med Oncol 17:111-116
16. Jamadar DA, Kazerooni EA, Daly BD, White CS, Gross BH (1995) Pulmonary zygomycosis: CT appearance. J Comput Assist Tomogr 19:733-738
17. John BV, Chamilos G, Kontoyiannis DP (2005) Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin Microbiol Infect 11:515-517
18. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II (2005) Zygomycosis in a tertiary-care center in the era of Aspergillus -active antifungal therapy: A case-control observation study of 27 recent cases. J Infect Dis 191:1350-1360
19. Krcmery V Jr, Kunova E, Jesenska Z, Trupl J, Spanik S, Mardiak J, Studena M, Kukuckova E (1996) Invasive mold infections in cancer patients: 5 years' experience with Aspergillus, Mucor, Fusarium and Acremonium infections. Support Care Cancer 4:39-45
20. Larkin JA, Montero JA (2003) Efficacy and safety of amphotericin B lipid complex for zygomycosis. Infect Med 20:201-206
21. Mantovani L, Hasenclever D, Krahl R, Pönisch W, Herold M, Pasold R, Fiedler F, Dölken G, Kämpfe D, Schmoll HJ, Subert R, Kubel M, Niederwieser D, Helbig W for the East German Hematology and Oncology Group (OSHO) (2002) Intermediate-dose cytarabine treatment delivered at moderate infusion rates for de novo acute myeloid leukemia-results of a phase I-II study. Leuk Lymphoma 43:265-274
22. Marty FM, Cosimi LA, Baden LR (2004) Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 350:950-952
23. McAdams HP, Rosado de Christenson M, Strollo DC, Patz EF Jr (1997) Pulmonary mucormycosis: Radiologic findings in 32 cases. Am J Roentgenol 168:1541-1548
24. Mori T, Egashira M, Kawamata N, Oshimi K, Nakamura K, Oguri T, Aida H, Hiruma A, Ichinohe M (2003) Zygomycosis: Two case reports and review of reported cases in the literature in Japan. Jpn J Med Mycol 44:163-179
25. Nosari A, Oreste P, Montillo M, Carrafiello G, Draisci M, Muti G, Molteni A, Morra E (2000) Mucormycosis in hematologic malignancies: An emerging fungal infection. Haematologica 85:1068-1071
26. Nosari A, Anghilieri M, Carrafiello G, Guffanti C, Marbello L, Montillo M, Muti G, Ribera S, Vanzulli A, Nichelatti M, Morra E (2003) Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies. Haematologica 88:1405-1409
27. Oren I (2005) Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia. Clin Infect Dis 40:770-771
28. Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, Cenacchi A, Pacilli L, Fabbiano F, Del Favero A (1997) Mucormycosis in patients with haematological malignancies: A retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematolgiche Malgine dell'Adulto). Br J Haematol 99:331-336
29. Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Piccardi M, Corvatta L, D'Antonio D, Girmenia C, Martino P, Del Favero A for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Infection Program (2004) Mucormycosis in hematologic patients. Haematologica 89:207-214
30. Pfaffenbach B, Donhuijsen K, Pahnke J, Bug R, Adamek RJ, Wegener M, Ricken D (1994) Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients. Med Klin 89:299-304
31. Prabhu RM, Patel R (2004) Mucormycosis and entomophthoramycosis: A review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 10(suppl 1):31-47
32. Rickerts V, Böhme A, Just-Nubling G (2002) Risk factor for invasive zygomycosis in patients with hematologic malignancies. Mycoses 45(suppl 1):27-30
33. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP (2005) Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 41:634-653
34. Sammassimo S, Mazzotta S, Tozzi M, Gentili S, Lenoci M, Santopietro R, Bucalossi A, Bocchia M, Lauria F (2004) Disseminated mucormycosis in a patient with acute myeloblastic leukemia misdiagnosed as infection by Enterococcus faecium. J Clin Microbiol 42:487-489
35. Sugar AM (2004) Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases. Elsevier, Philadelphia, pp 2973-2984
36. Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR (2002) In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother 46:2310-2312
37. Tarrand JJ, Lichterfeld M, Warraich I, Luna M, Han XY, May GS, Kontoyiannis DP (2003) Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 119:854-858
38. Vigouroux S, Morin O, Moreau P, Mechinaud F, Morineau N, Mahe B, Chevallier P, Guillaume T, Dubruille V, Harousseau JL, Milpied N (2005) Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: Attention required. Clin Infect Dis 40:e35-e37
39. Yeung CK, Cheng VCC, Lie AKW, Yuen KY (2001) Invasive disease due to mucorales: A case report and review of the literature. Hong Kong Med J 7:180-187